APA (7th ed.) Citation

Morimoto, K., Moriwaki, K., Nishikawa, Y., Maeda, T., Toyama, M., Agatsuma, N., . . . Nakayama, T. (2026). Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan. PharmacoEconomics - Open, 10(3), 471. https://doi.org/10.1007/s41669-025-00634-7

Chicago Style (17th ed.) Citation

Morimoto, Kosuke, et al. "Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan." PharmacoEconomics - Open 10, no. 3 (2026): 471. https://doi.org/10.1007/s41669-025-00634-7.

MLA (9th ed.) Citation

Morimoto, Kosuke, et al. "Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan." PharmacoEconomics - Open, vol. 10, no. 3, 2026, p. 471, https://doi.org/10.1007/s41669-025-00634-7.